{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:17:39Z","timestamp":1792786659044,"version":"4.5.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"Norte Portugal Regional Operational Programme","award":["NORTE-01-0145-FEDER-000012"],"award-info":[{"award-number":["NORTE-01-0145-FEDER-000012"]}]},{"name":"PORTUGAL 2020 Partnership Agreement"},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"name":"FEDER - Fundo Europeu de Desenvolvimento Regional"},{"name":"COMPETE 2020 - Operacional Programme for Competitiveness and Internationalisation"},{"name":"Portugal 2020"},{"name":"Portuguese funds through FCT - Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia\/ Minist\u00e9rio da Ci\u00eancia","id":[{"id":"https:\/\/ror.org\/00snfqn58","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Tecnologia e Ensino Superior in the framework of the project \u201c Institute for Research and Innovation in Health Sciences","award":["UID\/BIM\/04293\/2019"],"award-info":[{"award-number":["UID\/BIM\/04293\/2019"]}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BD\/117598\/2016"],"award-info":[{"award-number":["SFRH\/BD\/117598\/2016"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"name":"i3S Scientific Platforms: Biointerfaces and Nanotechnology","award":["FCT - UID\/BIM\/04293\/2019"],"award-info":[{"award-number":["FCT - UID\/BIM\/04293\/2019"]}]},{"name":"Histology and Electron Microscopy","award":["PPBI-POCI-01-0145-FEDER-022122"],"award-info":[{"award-number":["PPBI-POCI-01-0145-FEDER-022122"]}]},{"name":"Animal Facility"},{"DOI":"10.13039\/501100004787","name":"the Research Council of Norway","doi-asserted-by":"publisher","award":["274993"],"award-info":[{"award-number":["274993"]}],"id":[{"id":"10.13039\/501100004787","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.jconrel.2020.08.005","type":"journal-article","created":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T20:56:34Z","timestamp":1596747394000},"page":"161-173","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":83,"special_numbering":"C","title":["Engineered albumin-functionalized nanoparticles for improved FcRn binding enhance oral delivery of insulin"],"prefix":"10.1016","volume":"327","author":[{"given":"Cl\u00e1udia","family":"Azevedo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeannette","family":"Nilsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Algirdas","family":"Grevys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rute","family":"Nunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Terje","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Sarmento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2020.08.005_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2019.107843","article-title":"Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the international diabetes federation diabetes atlas, 9(th) edition","volume":"157","author":"Saeedi","year":"2019","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.jconrel.2020.08.005_bb0010","doi-asserted-by":"crossref","first-page":"963","DOI":"10.2337\/dc17-1962","article-title":"Global economic burden of diabetes in adults: projections from 2015 to 2030","volume":"41","author":"Bommer","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jconrel.2020.08.005_bb0015","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/dme.12128","article-title":"Real-world factors affecting adherence to insulin therapy in patients with type 1 or type 2 diabetes mellitus: a systematic review","volume":"30","author":"Davies","year":"2013","journal-title":"Diabetic Med."},{"key":"10.1016\/j.jconrel.2020.08.005_bb0020","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.biotechadv.2015.02.010","article-title":"Polymer-based nanoparticles for oral insulin delivery: revisited approaches","volume":"33","author":"Fonte","year":"2015","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.jconrel.2020.08.005_bb0025","series-title":"Delivery Technologies for Biopharmaceuticals: Peptides, Proteins, Nucleic Acids and Vaccines","first-page":"207","article-title":"Polymer-based delivery systems for oral delivery of peptides and proteins","author":"Sarmento","year":"2009"},{"key":"10.1016\/j.jconrel.2020.08.005_bb0030","doi-asserted-by":"crossref","first-page":"9199","DOI":"10.1016\/j.biomaterials.2014.07.026","article-title":"The impact of nanoparticles on the mucosal translocation and transport of GLP-1 across the intestinal epithelium","volume":"35","author":"Araujo","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2020.08.005_bb0035","doi-asserted-by":"crossref","first-page":"650","DOI":"10.2174\/1389201015666140915152330","article-title":"Targeting membrane transporters and receptors as a mean to optimize orally delivered biotechnological based drugs through nanoparticle delivery systems","volume":"15","author":"Pereira","year":"2014","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.jconrel.2020.08.005_bb0040","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2174\/1567201811310010004","article-title":"Nanoparticle targeting to inflamed tissues of the gastrointestinal tract","volume":"10","author":"Moulari","year":"2013","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.jconrel.2020.08.005_bb0045","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ijpharm.2012.03.056","article-title":"Oral delivery of therapeutic protein\/peptide for diabetes-future perspectives","volume":"440","author":"Rekha","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2020.08.005_bb0050","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2014.00682","article-title":"Unraveling the interaction between FcRn and albumin: opportunities for design of albumin-based therapeutics","volume":"5","author":"Sand","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2020.08.005_bb0055","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1007\/s11095-013-1212-3","article-title":"Human and non-human primate intestinal FcRn expression and immunoglobulin G transcytosis","volume":"31","author":"Hornby","year":"2014","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2020.08.005_bb0060","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1172\/JCI6968","article-title":"Bidirectional FcRn-dependent IgG transport in a polarized human intestinal epithelial cell line","volume":"104","author":"Dickinson","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2020.08.005_bb0065","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/nri2155","article-title":"FcRn: the neonatal fc receptor comes of age","volume":"7","author":"Roopenian","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2020.08.005_bb0070","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms1607","article-title":"Structure-based mutagenesis reveals the albumin-binding site of the neonatal fc receptor","volume":"3","author":"Andersen","year":"2012","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2020.08.005_bb0075","doi-asserted-by":"crossref","first-page":"213ra167","DOI":"10.1126\/scitranslmed.3007049","article-title":"Transepithelial transport of fc-targeted nanoparticles by the neonatal fc receptor for oral delivery","volume":"5","author":"Pridgen","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2020.08.005_bb0080","article-title":"Fc-modified exenatide-loaded nanoparticles for oral delivery to improve hypoglycemic effects in mice","volume":"8","author":"Shi","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2020.08.005_bb0085","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3816\/CBC.2005.n.042","article-title":"North central cancer treatment group N0531: phase II trial of weekly albumin-bound paclitaxel (ABI-007; Abraxane\u00ae) in combination with gemcitabine in patients with metastatic breast cancer","volume":"6","author":"Moreno-Aspitia","year":"2005","journal-title":"Clin. Breast Cancer"},{"key":"10.1016\/j.jconrel.2020.08.005_bb0090","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.2217\/nnm-2018-0029","article-title":"Intestinal uptake and transport of albumin nanoparticles: potential for oral delivery","volume":"13","author":"Hashem","year":"2018","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2020.08.005_bb0095","doi-asserted-by":"crossref","DOI":"10.1002\/smll.201800462","article-title":"Engineered multifunctional albumin-decorated porous silicon nanoparticles for FcRn translocation of insulin","volume":"14","author":"Martins","year":"2018","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2020.08.005_bb0100","doi-asserted-by":"crossref","DOI":"10.1038\/s42003-020-0903-7","article-title":"An intact C-terminal end of albumin is required for its long half-life in humans","volume":"3","author":"Nilsen","year":"2020","journal-title":"Commun. Biol."},{"key":"10.1016\/j.jconrel.2020.08.005_bb0105","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-03061-x","article-title":"A human endothelial cell-based recycling assay for screening of FcRn targeted molecules","volume":"9","author":"Grevys","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2020.08.005_bb0110","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1021\/bm5010383","article-title":"Stability study perspective of the effect of freeze-drying using cryoprotectants on the structure of insulin loaded into PLGA nanoparticles","volume":"15","author":"Fonte","year":"2014","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2020.08.005_bb0115","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1007\/s11095-016-2004-3","article-title":"Effect of the freezing step in the stability and bioactivity of protein-loaded PLGA nanoparticles upon lyophilization","volume":"33","author":"Fonte","year":"2016","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2020.08.005_bb0120","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/bmc.616","article-title":"Development and validation of a rapid reversed-phase HPLC method for the determination of insulin from nanoparticulate systems","volume":"20","author":"Sarmento","year":"2006","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.jconrel.2020.08.005_bb0125","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-03959-4","article-title":"A new paradigm for antiangiogenic therapy through controlled release of bevacizumab from PLGA nanoparticles","volume":"7","author":"Sousa","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2020.08.005_bb0130","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1002\/jps.21736","article-title":"Analysis of insulin allostery in solution and solid state with FTIR","volume":"98","author":"Maltesen","year":"2009","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2020.08.005_bb0135","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.4049\/jimmunol.170.7.3528","article-title":"The MHC class I-like IgG receptor controls perinatal IgG transport, IgG homeostasis, and fate of IgG-fc-coupled drugs","volume":"170","author":"Roopenian","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2020.08.005_bb0140","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1021\/bm0703923","article-title":"Oral bioavailability of insulin contained in polysaccharide nanoparticles","volume":"8","author":"Sarmento","year":"2007","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2020.08.005_bb0145","doi-asserted-by":"crossref","first-page":"13492","DOI":"10.1074\/jbc.M114.549832","article-title":"Extending serum half-life of albumin by engineering neonatal fc receptor (FcRn) binding","volume":"289","author":"Andersen","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2020.08.005_bb0150","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ejpb.2018.03.005","article-title":"Impact of surfactants on the target recognition of fab-conjugated PLGA nanoparticles","volume":"127","author":"Kennedy","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2020.08.005_bb0155","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.ijpharm.2018.08.016","article-title":"Carcinoembryonic antigen-targeted nanoparticles potentiate the delivery of anticancer drugs to colorectal cancer cells","volume":"549","author":"Pereira","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2020.08.005_bb0160","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","article-title":"PEGylation as a strategy for improving nanoparticle-based drug and gene delivery","volume":"99","author":"Suk","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2020.08.005_bb0165","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.addr.2017.08.010","article-title":"PEGylation for enhancing nanoparticle diffusion in mucus","volume":"124","author":"Huckaby","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2020.08.005_bb0170","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-00600-w","article-title":"Mechanistic understanding of in vivo protein corona formation on polymeric nanoparticles and impact on pharmacokinetics","volume":"8","author":"Bertrand","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2020.08.005_bb0175","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ejpb.2012.11.030","article-title":"Adsorption of plasma proteins on uncoated PLGA nanoparticles","volume":"85","author":"Sempf","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2020.08.005_bb0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0107408","article-title":"Plasma protein corona modulates the vascular wall interaction of drug carriers in a material and donor specific manner","volume":"9","author":"Sobczynski","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2020.08.005_bb0185","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1021\/jp8092012","article-title":"Structural analysis of human serum albumin complexes with cationic lipids","volume":"113","author":"Charbonneau","year":"2009","journal-title":"J. Phys. Chem."},{"key":"10.1016\/j.jconrel.2020.08.005_bb0190","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1016\/j.bmc.2005.12.034","article-title":"Binding analysis of glycyrrhetinic acid to human serum albumin: fluorescence spectroscopy, FTIR, and molecular modeling","volume":"14","author":"Tang","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jconrel.2020.08.005_bb0195","first-page":"183","article-title":"Intraluminal pH of the human gastrointestinal tract","volume":"46","author":"Fallingborg","year":"1999","journal-title":"Dan. Med. Bull."},{"key":"10.1016\/j.jconrel.2020.08.005_bb0200","doi-asserted-by":"crossref","first-page":"877","DOI":"10.2147\/IJN.S18905","article-title":"Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents","volume":"6","author":"Dinarvand","year":"2011","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2020.08.005_bb0205","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ijpharm.2018.02.045","article-title":"Oral insulin delivery, the challenge to increase insulin bioavailability: influence of surface charge in nanoparticle system","volume":"542","author":"Czuba","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2020.08.005_bb0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cis.2018.02.002","article-title":"Encapsulation, protection, and delivery of bioactive proteins and peptides using nanoparticle and microparticle systems: a review","volume":"253","author":"McClements","year":"2018","journal-title":"Adv. Colloid Interf. Sci."},{"key":"10.1016\/j.jconrel.2020.08.005_bb0215","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1081\/DDC-43985","article-title":"Reduction in the initial-burst release by surface crosslinking of PLGA microparticles containing hydrophilic or hydrophobic drugs","volume":"31","author":"Thote","year":"2005","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jconrel.2020.08.005_bb0220","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ijpharm.2007.06.028","article-title":"Human serum albumin (HSA) nanoparticles: reproducibility of preparation process and kinetics of enzymatic degradation","volume":"347","author":"Langer","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2020.08.005_bb0225","doi-asserted-by":"crossref","first-page":"20155","DOI":"10.1039\/C5RA26224K","article-title":"Impact of the in vitro gastrointestinal passage of biopolymer-based nanoparticles on insulin absorption","volume":"6","author":"Lopes","year":"2016","journal-title":"RSC Adv."},{"key":"10.1016\/j.jconrel.2020.08.005_bb0230","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.ijpharm.2015.10.032","article-title":"Co-encapsulation of lyoprotectants improves the stability of protein-loaded PLGA nanoparticles upon lyophilization","volume":"496","author":"Fonte","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2020.08.005_bb0235","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ijpharm.2016.03.011","article-title":"Annealing as a tool for the optimization of lyophilization and ensuring of the stability of protein-loaded PLGA nanoparticles","volume":"503","author":"Fonte","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2020.08.005_bb0240","doi-asserted-by":"crossref","first-page":"329","DOI":"10.4161\/biom.23246","article-title":"Effect of cryoprotectants on the porosity and stability of insulin-loaded PLGA nanoparticles after freeze-drying","volume":"2","author":"Fonte","year":"2012","journal-title":"Biomatter"},{"key":"10.1016\/j.jconrel.2020.08.005_bb0245","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0167-4838(95)00156-O","article-title":"Fourier-transform infrared spectroscopic investigation of protein stability in the lyophilized form","volume":"1253","author":"Costantino","year":"1995","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jconrel.2020.08.005_bb0250","doi-asserted-by":"crossref","DOI":"10.1088\/1742-6596\/769\/1\/012016","article-title":"FTIR study of secondary structure of bovine serum albumin and ovalbumin","volume":"769","author":"Abrosimova","year":"2016","journal-title":"J. Phys. Conf. Ser."},{"key":"10.1016\/j.jconrel.2020.08.005_bb0255","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2165\/00063030-200822040-00002","article-title":"Strategies toward the improved oral delivery of insulin nanoparticles via gastrointestinal uptake and translocation","volume":"22","author":"Woitiski","year":"2008","journal-title":"BioDrugs."},{"key":"10.1016\/j.jconrel.2020.08.005_bb0260","doi-asserted-by":"crossref","first-page":"17498","DOI":"10.1073\/pnas.1313839110","article-title":"Oral delivery system prolongs blood circulation of docetaxel nanocapsules via lymphatic absorption","volume":"110","author":"Attili-Qadri","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2020.08.005_bb0265","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nrd1067","article-title":"Challenges for the oral delivery of macromolecules","volume":"2","author":"Goldberg","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2020.08.005_bb0270","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-32817-0","article-title":"Human and mouse albumin bind their respective neonatal fc receptors differently","volume":"8","author":"Nilsen","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2020.08.005_bb0275","doi-asserted-by":"crossref","first-page":"34583","DOI":"10.1074\/jbc.M114.587675","article-title":"Interaction with both domain I and III of albumin is required for optimal pH-dependent binding to the neonatal fc receptor (FcRn)","volume":"289","author":"Sand","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2020.08.005_bb0280","doi-asserted-by":"crossref","first-page":"4826","DOI":"10.1074\/jbc.M109.081828","article-title":"Cross-species binding analyses of mouse and human neonatal fc receptor show dramatic differences in immunoglobulin G and albumin binding","volume":"285","author":"Andersen","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2020.08.005_bb0285","doi-asserted-by":"crossref","first-page":"390","DOI":"10.2337\/diabetes.55.02.06.db05-0686","article-title":"Considerations in the design of hyperinsulinemic-euglycemic clamps in the conscious mouse","volume":"55","author":"Ayala","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.jconrel.2020.08.005_bb0290","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1242\/dmm.006239","article-title":"Standard operating procedures for describing and performing metabolic tests of glucose homeostasis in mice","volume":"3","author":"Ayala","year":"2010","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.jconrel.2020.08.005_bb0295","doi-asserted-by":"crossref","first-page":"6849","DOI":"10.1016\/j.biomaterials.2010.05.042","article-title":"Biodistribution, pharmacodynamics and pharmacokinetics of insulin analogues in a rat model: Oral delivery using pH-responsive nanoparticles vs. subcutaneous injection","volume":"31","author":"Sonaje","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2020.08.005_bb0300","doi-asserted-by":"crossref","first-page":"269","DOI":"10.4103\/0250-474X.42967","article-title":"Protein and peptide drug delivery: oral approaches","volume":"70","author":"Shaji","year":"2008","journal-title":"Indian J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2020.08.005_bb0305","first-page":"374","article-title":"Study on preparation and oral efficacy of insulin-loaded poly(lactic-co-glycolic acid) nanoparticles","volume":"37","author":"Pan","year":"2002","journal-title":"Acta Pharm. Sin."},{"key":"10.1016\/j.jconrel.2020.08.005_bb0310","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/jps.20750","article-title":"Preparation of insulin loaded PLGA-Hp55 nanoparticles for oral delivery","volume":"96","author":"Cui","year":"2007","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2020.08.005_bb0315","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1023\/A:1018853506830","article-title":"Ontogenetic development and distribution of antibody transport and fc receptor mRNA expression in rat intestine","volume":"42","author":"Martin","year":"1997","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.jconrel.2020.08.005_bb0320","doi-asserted-by":"crossref","first-page":"4595","DOI":"10.4049\/jimmunol.1403014","article-title":"FcRn: the architect behind the immune and nonimmune functions of IgG and albumin","volume":"194","author":"Pyzik","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2020.08.005_bb0325","doi-asserted-by":"crossref","DOI":"10.3390\/biom8040115","article-title":"FcRn expression in Wildtype mice, transgenic mice, and in human tissues","volume":"8","author":"Li","year":"2018","journal-title":"Biomolecules"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365920304363?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365920304363?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T23:10:00Z","timestamp":1718406600000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365920304363"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":65,"alternative-id":["S0168365920304363"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2020.08.005","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Engineered albumin-functionalized nanoparticles for improved FcRn binding enhance oral delivery of insulin","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2020.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}